Empowering Pet Drug Development
Who We Are?
Pet drug research and development is a rigorous and highly complex process. It cannot simply follow the model for human drugs, but requires a deep understanding of species-specific factors such as the unique physiology, disease mechanisms, and drug metabolism differences in pets like dogs and cats.
Protheragen PawDiscover is a company dedicated to pet disease research and drug development. We offer clients comprehensive, end-to-end drug development services, spanning from building pet disease models, screening and optimizing drug candidates based on species characteristics, conducting rigorous preclinical studies and clinical trials compliant with veterinary drug regulations, all the way to final regulatory approval. We are committed to helping clients mitigate R&D risks and accelerate the time-to-market for pet drugs.
You Can Trust Us
“Collaborating with Protheragen PawDiscover on the development of our novel canine anti-inflammatory drug was a highly efficient and fruitful experience. Their profound knowledge of pet diseases, expertise in model construction, and efficient execution of preclinical studies saved us significant time.”
“When seeking a partner for the preclinical evaluation of a complex drug treating feline chronic kidney disease, the expert team at Protheragen PawDiscover demonstrated remarkable professionalism. They truly understand the unique physiology and disease characteristics of cats, and the study protocol they proposed was highly insightful. The data quality was impeccable, providing a solid foundation for subsequent decision-making.”
“Our company aimed to 'repurpose' some human drug candidate compounds for veterinary use, but this was entirely outside our area of expertise. Protheragen PawDiscover applied their specialized knowledge in veterinary drug research and development to help us formulate a highly feasible development strategy. Their expertise enabled us to successfully venture into the field of pet pharmaceuticals.”
“Protheragen PawDiscover provided critical support for the functional validation of our pet drug. They not only rapidly established evaluation models that met our requirements but also demonstrated capabilities and execution that far exceeded our expectations. They are a trusted long-term scientific partner.”
Why Choose Us?
Rich Experience & Expertise
Our core team comprises seasoned pathologists, molecular biologists, pharmacologists, and toxicologists, averaging over 5 years of industry experience. This ensures that pet drug development program designs are more rational, data interpretation is more accurate, and effectively mitigates your pet drug R&D risks.
Extensive Model Library
We maintain a diverse repository of pet disease models spanning ophthalmology, neurology, cardiovascular, and other fields. This enables rapid matching of mature models to support client research, significantly reducing pet disease and drug development timelines.
Proven Regulatory Navigation
Our Regulatory Affairs team possesses indepth knowledge of pet drug registration regulations and guidelines in key global markets. This enables us to embed compliance into the R&D design from the very outset, helping you efficiently advance your pet drug development.
Flexible and Efficient Customized Services
We understand that each project is unique. Rejecting a one-size-fits-all approach, we provide flexible and tailored services based on your drug’s characteristics, target indications, development stage, and specific budget.
